Skin cells may reveal secrets of deadly aortic bulges
NCT ID NCT06786754
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at skin cells (fibroblasts) from people with Marfan syndrome and other genetic conditions that cause thoracic aortic aneurysms (a bulging of the main artery in the chest). Researchers want to find out how these cells behave differently and what genes or proteins are involved, which could lead to better ways to predict or treat the disease. The study involves 15 adults and does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARFAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiovascular Genetic Centre IRCCS Policlinico San Donato
San Donato Milanese, Milan, 20097, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Blood test may predict aneurysm surgery need in marfan patients
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- New registry aims to unlock mysteries of Pregnancy-Related aortic tears